This report aims to provide a comprehensive presentation of the global market for Prosthetic Joint Infections Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prosthetic Joint Infections Treatment. This report contains market size and forecasts of Prosthetic Joint Infections Treatment in global, including the following market information:
Global Prosthetic Joint Infections Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Prosthetic Joint Infections Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Fusidic acid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prosthetic Joint Infections Treatment include Cempra Inc, Motif Bio Plc, Nabriva Therapeutics AG, Telephus Medical LLC and TenNor Therapeutics Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prosthetic Joint Infections Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prosthetic Joint Infections Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Prosthetic Joint Infections Treatment Market Segment Percentages, by Type, 2022 (%)
Fusidic acid
Lefamulin Acetate
MTF-101
TNP-2092
Others
Global Prosthetic Joint Infections Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Prosthetic Joint Infections Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Prosthetic Joint Infections Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Prosthetic Joint Infections Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prosthetic Joint Infections Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prosthetic Joint Infections Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cempra Inc
Motif Bio Plc
Nabriva Therapeutics AG
Telephus Medical LLC
TenNor Therapeutics Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prosthetic Joint Infections Treatment, market overview.
Chapter 2: Global Prosthetic Joint Infections Treatment market size in revenue.
Chapter 3: Detailed analysis of Prosthetic Joint Infections Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prosthetic Joint Infections Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prosthetic Joint Infections Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prosthetic Joint Infections Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prosthetic Joint Infections Treatment Overall Market Size
2.1 Global Prosthetic Joint Infections Treatment Market Size: 2022 VS 2030
2.2 Global Prosthetic Joint Infections Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prosthetic Joint Infections Treatment Players in Global Market
3.2 Top Global Prosthetic Joint Infections Treatment Companies Ranked by Revenue
3.3 Global Prosthetic Joint Infections Treatment Revenue by Companies
3.4 Top 3 and Top 5 Prosthetic Joint Infections Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prosthetic Joint Infections Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prosthetic Joint Infections Treatment Players in Global Market
3.6.1 List of Global Tier 1 Prosthetic Joint Infections Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Prosthetic Joint Infections Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prosthetic Joint Infections Treatment Market Size Markets, 2022 & 2030
4.1.2 Fusidic acid
4.1.3 Lefamulin Acetate
4.1.4 MTF-101
4.1.5 TNP-2092
4.1.6 Others
4.2 By Type - Global Prosthetic Joint Infections Treatment Revenue & Forecasts
4.2.1 By Type - Global Prosthetic Joint Infections Treatment Revenue, 2018-2023
4.2.2 By Type - Global Prosthetic Joint Infections Treatment Revenue, 2024-2030
4.2.3 By Type - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prosthetic Joint Infections Treatment Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Prosthetic Joint Infections Treatment Revenue & Forecasts
5.2.1 By Application - Global Prosthetic Joint Infections Treatment Revenue, 2018-2023
5.2.2 By Application - Global Prosthetic Joint Infections Treatment Revenue, 2024-2030
5.2.3 By Application - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prosthetic Joint Infections Treatment Market Size, 2022 & 2030
6.2 By Region - Global Prosthetic Joint Infections Treatment Revenue & Forecasts
6.2.1 By Region - Global Prosthetic Joint Infections Treatment Revenue, 2018-2023
6.2.2 By Region - Global Prosthetic Joint Infections Treatment Revenue, 2024-2030
6.2.3 By Region - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prosthetic Joint Infections Treatment Revenue, 2018-2030
6.3.2 US Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.3.3 Canada Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.3.4 Mexico Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prosthetic Joint Infections Treatment Revenue, 2018-2030
6.4.2 Germany Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.4.3 France Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.4.4 U.K. Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.4.5 Italy Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.4.6 Russia Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.4.8 Benelux Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prosthetic Joint Infections Treatment Revenue, 2018-2030
6.5.2 China Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.5.3 Japan Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.5.4 South Korea Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.5.6 India Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prosthetic Joint Infections Treatment Revenue, 2018-2030
6.6.2 Brazil Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.6.3 Argentina Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prosthetic Joint Infections Treatment Revenue, 2018-2030
6.7.2 Turkey Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.7.3 Israel Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Prosthetic Joint Infections Treatment Market Size, 2018-2030
6.7.5 UAE Prosthetic Joint Infections Treatment Market Size, 2018-2030
7 Prosthetic Joint Infections Treatment Companies Profiles
7.1 Cempra Inc
7.1.1 Cempra Inc Company Summary
7.1.2 Cempra Inc Business Overview
7.1.3 Cempra Inc Prosthetic Joint Infections Treatment Major Product Offerings
7.1.4 Cempra Inc Prosthetic Joint Infections Treatment Revenue in Global Market (2018-2023)
7.1.5 Cempra Inc Key News & Latest Developments
7.2 Motif Bio Plc
7.2.1 Motif Bio Plc Company Summary
7.2.2 Motif Bio Plc Business Overview
7.2.3 Motif Bio Plc Prosthetic Joint Infections Treatment Major Product Offerings
7.2.4 Motif Bio Plc Prosthetic Joint Infections Treatment Revenue in Global Market (2018-2023)
7.2.5 Motif Bio Plc Key News & Latest Developments
7.3 Nabriva Therapeutics AG
7.3.1 Nabriva Therapeutics AG Company Summary
7.3.2 Nabriva Therapeutics AG Business Overview
7.3.3 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Major Product Offerings
7.3.4 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue in Global Market (2018-2023)
7.3.5 Nabriva Therapeutics AG Key News & Latest Developments
7.4 Telephus Medical LLC
7.4.1 Telephus Medical LLC Company Summary
7.4.2 Telephus Medical LLC Business Overview
7.4.3 Telephus Medical LLC Prosthetic Joint Infections Treatment Major Product Offerings
7.4.4 Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue in Global Market (2018-2023)
7.4.5 Telephus Medical LLC Key News & Latest Developments
7.5 TenNor Therapeutics Ltd
7.5.1 TenNor Therapeutics Ltd Company Summary
7.5.2 TenNor Therapeutics Ltd Business Overview
7.5.3 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Major Product Offerings
7.5.4 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue in Global Market (2018-2023)
7.5.5 TenNor Therapeutics Ltd Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prosthetic Joint Infections Treatment Market Opportunities & Trends in Global Market
Table 2. Prosthetic Joint Infections Treatment Market Drivers in Global Market
Table 3. Prosthetic Joint Infections Treatment Market Restraints in Global Market
Table 4. Key Players of Prosthetic Joint Infections Treatment in Global Market
Table 5. Top Prosthetic Joint Infections Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prosthetic Joint Infections Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prosthetic Joint Infections Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prosthetic Joint Infections Treatment Product Type
Table 9. List of Global Tier 1 Prosthetic Joint Infections Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prosthetic Joint Infections Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Prosthetic Joint Infections Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prosthetic Joint Infections Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Prosthetic Joint Infections Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prosthetic Joint Infections Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Prosthetic Joint Infections Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prosthetic Joint Infections Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2024-2030
Table 30. Cempra Inc Company Summary
Table 31. Cempra Inc Prosthetic Joint Infections Treatment Product Offerings
Table 32. Cempra Inc Prosthetic Joint Infections Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Cempra Inc Key News & Latest Developments
Table 34. Motif Bio Plc Company Summary
Table 35. Motif Bio Plc Prosthetic Joint Infections Treatment Product Offerings
Table 36. Motif Bio Plc Prosthetic Joint Infections Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Motif Bio Plc Key News & Latest Developments
Table 38. Nabriva Therapeutics AG Company Summary
Table 39. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Product Offerings
Table 40. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Nabriva Therapeutics AG Key News & Latest Developments
Table 42. Telephus Medical LLC Company Summary
Table 43. Telephus Medical LLC Prosthetic Joint Infections Treatment Product Offerings
Table 44. Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Telephus Medical LLC Key News & Latest Developments
Table 46. TenNor Therapeutics Ltd Company Summary
Table 47. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Product Offerings
Table 48. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. TenNor Therapeutics Ltd Key News & Latest Developments
List of Figures
Figure 1. Prosthetic Joint Infections Treatment Segment by Type in 2022
Figure 2. Prosthetic Joint Infections Treatment Segment by Application in 2022
Figure 3. Global Prosthetic Joint Infections Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prosthetic Joint Infections Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prosthetic Joint Infections Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prosthetic Joint Infections Treatment Revenue in 2022
Figure 8. By Type - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 16. US Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 28. China Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Prosthetic Joint Infections Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. Cempra Inc Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Motif Bio Plc Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
